Skip to main content
OpenTrials

Clinical trial condition

Narcolepsy

Explore clinical trials studying Narcolepsy. Study availability and eligibility vary by location and protocol.

87 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Narcolepsy trial results

Completed

Study of the Academic and Professional Course of Narcoleptic Patients (NARCOSCOL-NARCOVITAE)

NCT03765892

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Centre de médecine du Sommeil CHU d'Angers Angers, France
  • Service d'Explorations Fonctionnelles du Système Nerveux, Clinique du Sommeil, CHU de Bordeaux Groupe Hospitalier Pellegrin Bordeaux, France
  • Unité de sommeil pédiatrique - Hôpital femme Mère Enfant - Hospices civils de Lyon Bron, France
  • Service de neurophysiologie clinique CHU de Dijon Dijon, France
View all 18 locations
View Trial Details
Completed

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

NCT05055024

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +6 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Sleep Medicine Center Redwood City, California, United States
  • Pacific Research Network San Diego, California, United States
  • St. Francis Sleep Allergy and Lung Institute Clearwater, Florida, United States
View all 22 locations
View Trial Details
Completed

Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy

NCT04923594

Conditions
Cataplexy Narcolepsy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Sleep Medicine Center Redwood City, California, United States
  • Pacific Research Network San Diego, California, United States
  • St. Francis Sleep Allergy and Lung Institute Clearwater, Florida, United States
View all 22 locations
View Trial Details
Completed

Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

NCT02720744

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +6 more
Locations
  • Pinnacle Research Group LLC Anniston, Alabama, United States
  • University Sleep Disorder Center Auburn, Alabama, United States
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Baptist Health Center for Clinical Research Little Rock, Arkansas, United States
View all 57 locations
View Trial Details
Completed

Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

NCT01624480

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +4 more
Locations
  • Teva Investigational Site 12 Birmingham, Alabama, United States
  • Teva Investigational Site 17 Birmingham, Alabama, United States
  • Teva Investigational Site 7 Little Rock, Arkansas, United States
  • Teva Investigational Site 18 Orange, California, United States
View all 24 locations
View Trial Details

Related conditions